$2.91
-0.33 (-10.06%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,499.7% upside
Low Target
$27.16
Average Target
$46.47
High Target
$57.70
Current Price
$2.91
Current
$2.91
$2.91
Target
$46.47
$46.47
$27.16
$46.47 avg
$57.70
Scenario Analysis
Bear Case
$27.16
834.9%
Low target
Base Case
$46.47
+1,499.7%
Avg target
Bull Case
$57.70
+1,886.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$10.99
-73.6% from high
52-Week Low
$2.55
+13.9% from low
Target vs 52W High
$46.47
+322.8% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $-0.34
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |